S&P says the health insurers it rates look strong
Possible threats to future performance include Medicare cuts and group health hits, analysts say.
3 effects of a possible Blues' individual health recovery
Analysts at Standard & Poor's Financial Services LLC have looked hard at the big individual major medical insurance issuers and detected a pulse.
Agents mobilize for ACA exchange plan scrambler week
HealthCare.gov will start mapping stranded exchange plan enrollees into new plans.
S&P: Commercial health may enter rougher waters
Analysts at the firm warn against complacency about Medicare and Medicaid risk.
S&P says Medicare Advantage issuers will be fine
The rate environment may be dreary, but CMS is being more transparent, analysts say.
FIA sales spotlighted in DOL rule
Fixed index annuities appear to be the product most affected by the Department of Labor’s new fiduciary standard regulation, according to analysts.
New DOL rule will force insurers to adapt
S&P analysts project that the final DOL fiduciary rule will have a particular impact on variable and fixed index annuities, a $190 billion market.
S&P: PPACA 3R's not our hot potato
An analyst says risk corridors woes should not be a concern for rated insurers.
Stocks fall, Treasuries gain in listless trade as Fed looms
Here's the forecasting rundown for stocks, bonds, currencies, emerging markets and commodities.
Surviving PPACA CO-OPs may have 475,000 enrollees
The nonprofit insurers may have averaged about $3,500 in premium revenue per 2014 enrollee.